Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Hypertension (Dallas, Tex. : 1979)
|
May 3, 2017
Risk Factors for Nonadherence to Antihypertensive Treatment
Pankaj Gupta, Prashanth Patel, Branislav Štrauch, et al.
NIHR Open Research
|
April 20, 2026
Randomised controlled trial of a very brief nurse-delivered intervention followed by a digital intervention to support medication adherence and reduce blood pressure in people prescribed treatment for hypertension in primary care: protocol for the Programme on Adherence to Medication (PAM) trial
Stephen Sutton, James Jamison, Katja Beardsell, et al.
The Lancet. Primary Care
|
June 18, 2026
Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trial
Maciej Tomaszewski, Pankaj Gupta, Philip Chowienczyk, et al.
Calcified Tissue International
|
November 8, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta
Jannie Dahl Hald, Christopher Weir, Catriona Keerie, et al.
JAMA
|
May 14, 2026
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial
Jannie Dahl Hald, Christopher J Weir, Catriona Keerie, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Hypertension (Dallas, Tex. : 1979)
|
May 3, 2017
Risk Factors for Nonadherence to Antihypertensive Treatment
Pankaj Gupta, Prashanth Patel, Branislav Štrauch, et al.
NIHR Open Research
|
April 20, 2026
Randomised controlled trial of a very brief nurse-delivered intervention followed by a digital intervention to support medication adherence and reduce blood pressure in people prescribed treatment for hypertension in primary care: protocol for the Programme on Adherence to Medication (PAM) trial
Stephen Sutton, James Jamison, Katja Beardsell, et al.
The Lancet. Primary Care
|
June 18, 2026
Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trial
Maciej Tomaszewski, Pankaj Gupta, Philip Chowienczyk, et al.
Calcified Tissue International
|
November 8, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta
Jannie Dahl Hald, Christopher Weir, Catriona Keerie, et al.
JAMA
|
May 14, 2026
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial
Jannie Dahl Hald, Christopher J Weir, Catriona Keerie, et al.
Page
of 5